FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2084480062> ?p ?o ?g. }

• W2084480062 endingPage "S38" @default.
• W2084480062 startingPage "S26" @default.
• W2084480062 abstract "There is a need for more efficacious inactivated influenza vaccines, since current formulations show suboptimal immunogenicity in at-risk populations, like the elderly. More effective vaccines are also urgently needed for an improved influenza pandemic preparedness. In this context, there is considerable interest in virosomes. Virosomes are virus-like particles, consisting of reconstituted influenza virus envelopes, lacking the genetic material of the native virus. Virosomes are produced from influenza virus through a detergent solubilization and removal procedure. Properly reconstituted virosomes retain the cell binding and membrane fusion properties of the native virus, mediated by the viral envelope glycoprotein haemagglutinin. These functional characteristics of virosomes form the basis for their enhanced immunogenicity. First, the repetitive arrangement of haemagglutinin molecules on the virosomal surface mediates a cooperative interaction of the antigen with Ig receptors on B lymphocytes, stimulating strong antibody responses. In addition, virosomes interact efficiently with antigen-presenting cells, such as dendritic cells, resulting in activation of T lymphocytes. In a murine model system, virosomes, as compared to conventional subunit vaccine, which consists of isolated influenza envelope glycoproteins, induce a more balanced T helper 1 versus T helper 2 response, virosomes in particular eliciting stronger T helper 1 responses than subunit vaccine. Also, as a result of fusion of the virosomes with the endosomal membrane, part of the virosomal antigen gains access to the major histocompatibility class I presentation pathway, thus priming cytotoxic T lymphocyte activity. Finally, virosomes represent an excellent platform for inclusion of lipophilic adjuvants for further stimulation of vaccine immunogenicity. By virtue of these characteristics, virosomes represent a promising novel class of inactivated influenza vaccines, which not only induce high virus-neutralizing antibody titres, but also prime the cellular arm of the immune system." @default.
• W2084480062 created "2016-06-24" @default.
• W2084480062 creator A5012996455 @default.
• W2084480062 creator A5018392015 @default.
• W2084480062 creator A5031412427 @default.
• W2084480062 creator A5035211563 @default.
• W2084480062 creator A5035254584 @default.
• W2084480062 creator A5047921978 @default.
• W2084480062 creator A5090086602 @default.
• W2084480062 date "2005-07-01" @default.
• W2084480062 modified "2023-10-18" @default.
• W2084480062 title "The virosome concept for influenza vaccines" @default.
• W2084480062 cites W1556770451 @default.
• W2084480062 cites W179238286 @default.
• W2084480062 cites W1951079563 @default.
• W2084480062 cites W1976528399 @default.
• W2084480062 cites W1978763290 @default.
• W2084480062 cites W1980575409 @default.
• W2084480062 cites W1981572327 @default.
• W2084480062 cites W1983305687 @default.
• W2084480062 cites W1983723406 @default.
• W2084480062 cites W1988729025 @default.
• W2084480062 cites W1994391392 @default.
• W2084480062 cites W1994742954 @default.
• W2084480062 cites W1995291654 @default.
• W2084480062 cites W1996493196 @default.
• W2084480062 cites W2000197169 @default.
• W2084480062 cites W2002392006 @default.
• W2084480062 cites W2005047889 @default.
• W2084480062 cites W2009296046 @default.
• W2084480062 cites W2010622646 @default.
• W2084480062 cites W2012171571 @default.
• W2084480062 cites W2013704309 @default.
• W2084480062 cites W2019850722 @default.
• W2084480062 cites W2020937457 @default.
• W2084480062 cites W2023871112 @default.
• W2084480062 cites W2024358588 @default.
• W2084480062 cites W2027741520 @default.
• W2084480062 cites W2030749429 @default.
• W2084480062 cites W2034832824 @default.
• W2084480062 cites W2036596307 @default.
• W2084480062 cites W2040143553 @default.
• W2084480062 cites W2044489248 @default.
• W2084480062 cites W2049387979 @default.
• W2084480062 cites W2052017398 @default.
• W2084480062 cites W2054790877 @default.
• W2084480062 cites W2056207626 @default.
• W2084480062 cites W2063554346 @default.
• W2084480062 cites W2071718034 @default.
• W2084480062 cites W2075356992 @default.
• W2084480062 cites W2076175178 @default.
• W2084480062 cites W2077025077 @default.
• W2084480062 cites W2087786242 @default.
• W2084480062 cites W2093011554 @default.
• W2084480062 cites W2093142379 @default.
• W2084480062 cites W2095044543 @default.
• W2084480062 cites W2099129693 @default.
• W2084480062 cites W2102335249 @default.
• W2084480062 cites W2102575018 @default.
• W2084480062 cites W2103670619 @default.
• W2084480062 cites W2107587363 @default.
• W2084480062 cites W2107857115 @default.
• W2084480062 cites W2110157529 @default.
• W2084480062 cites W2111220263 @default.
• W2084480062 cites W2116971894 @default.
• W2084480062 cites W2118155405 @default.
• W2084480062 cites W2118994333 @default.
• W2084480062 cites W2139556812 @default.
• W2084480062 cites W2139620037 @default.
• W2084480062 cites W2141633691 @default.
• W2084480062 cites W2143555562 @default.
• W2084480062 cites W2143871880 @default.
• W2084480062 cites W2147098571 @default.
• W2084480062 cites W2153975572 @default.
• W2084480062 cites W2156354112 @default.
• W2084480062 cites W2161208630 @default.
• W2084480062 cites W2171369029 @default.
• W2084480062 cites W236267061 @default.
• W2084480062 cites W4205978945 @default.
• W2084480062 cites W4231860838 @default.
• W2084480062 cites W4236880273 @default.
• W2084480062 cites W4250635800 @default.
• W2084480062 cites W4313344599 @default.
• W2084480062 doi "https://doi.org/10.1016/j.vaccine.2005.04.026" @default.
• W2084480062 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16026906" @default.
• W2084480062 hasPublicationYear "2005" @default.
• W2084480062 type Work @default.
• W2084480062 sameAs 2084480062 @default.
• W2084480062 citedByCount "201" @default.
• W2084480062 countsByYear W20844800622012 @default.
• W2084480062 countsByYear W20844800622013 @default.
• W2084480062 countsByYear W20844800622014 @default.
• W2084480062 countsByYear W20844800622015 @default.
• W2084480062 countsByYear W20844800622016 @default.
• W2084480062 countsByYear W20844800622017 @default.
• W2084480062 countsByYear W20844800622018 @default.
• W2084480062 countsByYear W20844800622019 @default.
• W2084480062 countsByYear W20844800622020 @default.

• next